This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Pharmacokinetics and Pharmacodynamics (PKPD) 2018 workshop

The Society's workshops are usually suitable for Masters level and above. Basic pharmacological knowledge is expected.

Register for event

21–22 Jun 2018

Abstracts deadline:

Registration deadline: 13 Jun 2018

London, UK - View map

  • Overview
  • Event programme
  • Social programme
  • Registration
  • Venue


This workshop covers the fundamental aspects of pharmacokinetics and pharmacodynamics. The workshop takes the format of lectures introducing concept, basic theory and practical examples reinforced with tutorials on data analysis and modelling and simulation. Students will be expected to play an active role (a calculator is required) in analysis, interpretation and discussion.

Learning Objectives

  • Introduction to the fundamental principles of pharmacokinetic (pk) and pharmacodynamic (pd) data analysis

  • Consideration of other contributory factors and processes that influence pk and pd measurements and outcomes

  • Appreciation and understanding of the importance and contribution of pk/pd by first intent to inform preclinical and clinical study design

Speaker information

Dr Phil Jeffrey: ( BSc, MSc, PhD is an independent consultant with over 35 years’ experience in the pharmaceutical industry.  Phil has a successful a successful track record in drug discovery from early lead optimisation through to clinical proof of mechanism and proof of concept.   Formerly Head of Translational Sciences in the Rare Diseases Research Unit at Pfizer, he has worked for The Upjohn Company, SmithKline Beecham and GlaxoSmithKline across a wide variety of therapeutic areas including; autoimmunity, inflammation, CNS, anti-infectives, epigenetics, cardiovascular and rare diseases.  Phil has a PhD in drug metabolism and pharmacokinetics from the University of Sheffield and has authored/co-authored over 50 papers and 4 book chapters.

James Clarke: Holds an MSc in Biochemistry from the University of Kent. James has 14 years’ postgraduate experience in the pharmaceutical industry across multiple disease areas within Pfizer, GSK, Shire, BTG and more recently AstraZeneca. James has held roles in drug target validation and clinical pharmacology but the majority of his career has been within DMPK supporting clinical development. In his current role, James performs the function of a DMPK Project Leader in an oncology therapy area, supporting drug development projects from candidate selection to product lifecycle.

Dr Pinky Dua: Senior Director of Clinical Pharmacology at Pfizer and is the Head of Clinical Pharmacology for the Rare Disease research unit. Pinky has over 10 years’ experience in the pharmaceutical industry and has strong scientific and technical background with proven track record in quantitative modelling and simulation for drug discovery and development. Pinky has worked across a wide variety of therapeutic areas – Pain, Neurology, Psychiatry, Respiratory, GI and Rare Diseases. Pinky has a PhD in Chemical Engineering from Imperial College London, has published over 20 journal and conference papers and six book chapters. Pinky has delivered invited/plenary talks at international pharmaceutical conferences and at academic institutions.
Rob Willis: Principal Scientist, Translational Sciences, Heptares Therapeutics providing strategic DMPK input across a number of diverse lead optimisation drug discovery programmes. Rob has over 13 years’ experience in the pharmaceutical industry with Heptares and formally GSK across a range of therapy areas. In his current role, Rob is responsible for the design and implementation of key DMPK and in vivo efficacy studies to evaluate molecules from start of chemistry through lead optimisation to candidate selection. He is experienced in PK, PK/PD and PBPK modelling including human PK and efficacious dose predictions from preclinical data and has a PhD investigating PK/PD modelling of acute inflammatory challenge models from the University of Strathclyde.

Download the latest workshop programme

For any questions please email


Workshop dinner:

A workshop dinner for speakers and delegates will be held on Thursday 21st June 2017. This is an excellent opportunity to meet and network with both the speakers and other delegates in an informal setting.

Dinner cost: £25

Fire and Stone
31/32 Maiden Lane
Covent Garden

Registration fees include attendance to the workshop and refreshments.

Delegates are required to bring a laptop to the workshop. You can hire a laptop from the BPS for £50 when you register online.

Early bird rates expire: Thursday 24th May 2018

   Early-bird rates   Standard rate  
 BPS Member Registration   £200 £250
Non-Member Registration £250 £300
Laptop hire N/A  £50  


King's College London
Strand Campus


Temple (District and Circle lines): 2 minute walk
Charing Cross (Bakerloo and Northern lines): 10 minute walk
Embankment (District, Circle and Bakerloo lines): 10 minute walk
Waterloo (Jubilee, Northern, Bakerloo, Waterloo & City lines): 12 minute walk
Holborn (Central and Picadilly lines): 12 minute walk
Chancery Lane (Central line): use exit 4 - 15 minute walk

Charing Cross: 9 minute walk
Waterloo: 12 minute walk
Waterloo East: 10 minute walk
Blackfriars: 12 minute walk

Buses stopping outside the university: 1, 4, 26, 59, 68, 76, X68, 168, 171, 172, 176 (24 hour), 188, 243 (24 hour), 341 (24 hour), 521, RV1.

There is no public parking, but a pay and display parking system operates in nearby streets including Surrey Street.

Tourist Information:
London's primary Tourist Information Centre is: Victoria Station Travel Information Centre. Opposite platform 8, Victoria Railway Station, London, SW1V 1JU, Tube: Victoria
For further information about London and locations of other tourist information, please visit their website.

British Pharmacological Society on-site contact details
Laura Neville - Education & Training Manager
Mobile: +44 (0) 7789 076273